Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 5
1987 5
1988 2
1989 6
1990 3
1991 2
1992 6
1993 15
1994 2
1995 2
1996 2
1997 3
1998 5
1999 9
2000 9
2001 12
2002 20
2003 13
2004 19
2005 19
2006 26
2007 38
2008 22
2009 15
2010 16
2011 30
2012 29
2013 18
2014 21
2015 23
2016 23
2017 24
2018 26
2019 38
2020 30
2021 42
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

526 results
Results by year
Filters applied: . Clear all
Page 1
Managing Lung Cancer with Comorbid Interstitial Pneumonia.
Ichihara E, Miyahara N, Maeda Y, Kiura K. Ichihara E, et al. Among authors: kiura k. Intern Med. 2020 Jan 15;59(2):163-167. doi: 10.2169/internalmedicine.3481-19. Epub 2019 Sep 18. Intern Med. 2020. PMID: 31534086 Free PMC article. Review.
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.
Watanabe H, Ichihara E, Kayatani H, Makimoto G, Ninomiya K, Nishii K, Higo H, Ando C, Okawa S, Nakasuka T, Kano H, Hara N, Hirabae A, Kato Y, Ninomiya T, Kubo T, Rai K, Ohashi K, Hotta K, Tabata M, Maeda Y, Kiura K. Watanabe H, et al. Among authors: kiura k. Cancer Sci. 2021 May;112(5):1853-1864. doi: 10.1111/cas.14801. Epub 2021 Mar 18. Cancer Sci. 2021. PMID: 33410241 Free PMC article.
Nivolumab for the treatment of unresectable pleural mesothelioma.
Hotta K, Fujimoto N, Kozuki T, Aoe K, Kiura K. Hotta K, et al. Among authors: kiura k. Expert Opin Biol Ther. 2020 Feb;20(2):109-114. doi: 10.1080/14712598.2020.1703945. Epub 2019 Dec 16. Expert Opin Biol Ther. 2020. PMID: 31825692 Review.
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.
Shaw AT, Kim TM, Crinò L, Gridelli C, Kiura K, Liu G, Novello S, Bearz A, Gautschi O, Mok T, Nishio M, Scagliotti G, Spigel DR, Deudon S, Zheng C, Pantano S, Urban P, Massacesi C, Viraswami-Appanna K, Felip E. Shaw AT, et al. Among authors: kiura k. Lancet Oncol. 2017 Jul;18(7):874-886. doi: 10.1016/S1470-2045(17)30339-X. Epub 2017 Jun 9. Lancet Oncol. 2017. PMID: 28602779 Clinical Trial.
Targeting angiogenesis in cancer therapy.
Ichihara E, Kiura K, Tanimoto M. Ichihara E, et al. Among authors: kiura k. Acta Med Okayama. 2011 Dec;65(6):353-62. doi: 10.18926/AMO/47260. Acta Med Okayama. 2011. PMID: 22189475 Free article. Review.
Medical treatment of mesothelioma: anything new?
Takigawa N, Kiura K, Kishimoto T. Takigawa N, et al. Among authors: kiura k. Curr Oncol Rep. 2011 Aug;13(4):265-71. doi: 10.1007/s11912-011-0172-1. Curr Oncol Rep. 2011. PMID: 21503595 Review.
526 results